Reuters reveals Singapore’s Temasek considers sale of Advanced MedTech, likely valued at about $1 bln

Reuters was once first to record Temasek Holdings is exploring promoting Complicated MedTech, after the clinical gadgets company, absolutely owned via the Singaporean state investor, gained passion from suitors, together with buyout budget. Two funding banks had been tapped to release a sale procedure for Singapore-headquartered MedTech, which might be valued at kind of $1 billion.